Michael H. Carrel - 30 Jun 2023 Form 4 Insider Report for AtriCure, Inc. (ATRC)

Role
President, CEO, & Director, Director
Signature
/s/ Allison Walker as Attorney-in-fact for Michael H. Carrel
Issuer symbol
ATRC
Transactions as of
30 Jun 2023
Net transactions value
+$21,227
Form type
4
Filing time
03 Jul 2023, 08:12:08 UTC
Previous filing
28 Jun 2023
Next filing
08 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRC Common Stock Award $21,227 +557 +0.09% $38.11 596,610 30 Jun 2023 Direct F1, F2
holding ATRC Common Stock 3,310 30 Jun 2023 Held by reporting person's children
holding ATRC Common Stock 1,000 30 Jun 2023 Held by reporting person's parents
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2023.
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 3, 2023, which is the first trading day of the applicable offering period. The closing price on January 3, 2023 was $44.84.